All the Active Ingredient Drugs
Antiprotozoal. Miltefosine 10 mg , 50 mg. HARD CAPS.: 56×10 mg, 50 mg, 28×50 mg. Visceral leishmaniasis: Bdy. wt. 30–31 kg, 60 mg dly. Bdy. wt. 32–39 kg, 80 mg dly. Bdy. wt. 40 kg and above, 100 mg dly. An incr. to 150 mg could be consid. in pts. with a bdy. wt. > 67 kg under monitor. of the tolerabil. Cutan.
leishmaniasis: The dly. dosage for child. aged 12 yrs. and older with a bdy. wt. of at least 30 kg, adolesc./ adult. with a bdy. wt < 45 kg is 100 mg miltefosine. Pts. with a bdy. wt. > 45 kg - 150 mg miltefosine dly. Should be taken withbmeals. Dosages of 2-8 hard caps./d
should be divid. into 2-3 individ. doses to be taken either in the morn. and even. or in the morn., at noon and in the even. The duration of tmt. is 28 d. Immuno-compr. pts. may require prolong. tmt. See lit.
Tmt. of visceral Leishmaniasis caused by Leishmania donovani , in adults/adoles.≥12 yrs. of age bdy. wt. ≥30 kg (66 lbs). Tmt. of cutan. Leishmaniasis caused by Leishmania brasiliensis complex or Leishmania mexicana complex, in adults/adoles. ≥12 yrs. of age bdy. wt. ≥30 kg (66 lbs).
C/I: Hypersens. Pre-exist. severe damage of liver/kidney funct. Sjögren - Larsson Syndr. Preg. and WOCBP who do not use a reliable contracep. during and up to 5 mnths. after tmt. Women who can become preg. and have not had a preg. test. Women who can get preg. must have a urine or blood preg.
test before taking this drug.
